Project Optimus – FDA’s New Dose Optimization \u0026 Selection Paradigm in Oncology Drug Development

(1:5:36)

Pharmacokinetics | Dosage Regimen

(24:19)

Why is dose optimization important?

(1:46)

Oncology Drug Development and Dose Optimization: What Are the Implications of Project Optimus?

(14:30)

Dose Optimization for Improved Outcomes in Refractory mCRC

(8:32)

What you should know about FDA Project Optimus for your oncology drug approval

(42:27)

Dose Selection and Optimization in the Adult Population with Dr. Yaning Wang

(1:7:16)

Dose Optimization for Particle Beam Therapy

(2:9)

Using Modeling and Simulation to Optimize Dosing of an Anti-Infective for Children

(44:57)

Dose Optimization: Finding the \

(5:49)

Bench to Bedside Chat Pharmacology and Dose Optimization for First-in-Human Oncology Trials

(1:27:6)

Getting the Best Dose: The Clinical Pharmacology Studies that Help Achieve this Goal

(48:50)

Dose Optimization: Why and Towards What End

(49:6)

How to Define \u0026 Measure Clinical Endpoints to Optimize Your Oncology Drug Dosing

(55:19)

Biologics: Dose optimization | Marc Bourcier, MD, FRCPC | Canada

(6:46)

Dose Number as a Tool to Guide Lead Optimization of Orally Bioavailable Compounds

(1:28)

Modeling and Simulation to Select Oncology Dosages - Session 1

(1:28:43)

BST Seminar | Continual Reassessment Methods for Dose Optimization | UAB School of Public Health

(42:35)

Dose optimization of inotuzumab ozogamicin in adult patients with R/R ALL

(42)